Maven Clinic Launches DTC Women’s Health Platform for GLP-1 and Fertility
Maven Clinic has launched the first U.S. Direct-to-consumer platform combining GLP-1 receptor agonists (like semaglutide) with personalized hormone therapy for women’s health—targeting polycystic ovary syndrome (PCOS), obesity-related metabolic dysfunction, and ... Read More